Article Details

OncoC4 Announces First Patient Dosed in Phase 1 Trial for Novel SIGLEC10 Immune ...

Retrieved on: 2024-09-04 16:47:18

Tags for this article:

Click the tags to see associated articles and topics

OncoC4 Announces First Patient Dosed in Phase 1 Trial for Novel SIGLEC10 Immune .... View article details on hiswai:

Excerpt

Home/Antibodies/OncoC4 Announces First Patient ... Discovered in house, ONC-841 is a humanized antagonist anti-SIGLEC10 monoclonal antibody.

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo